Opening book details…
About this Medicine article
Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors by Plummer, Ruth; Stephens, Peter; Aissat-Daudigny, Louiza; Cambois, Anne; Moachon, Gilbert; Brown, Peter D.; Campone, Mario is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Plummer, Ruth; Stephens, Peter; Aissat-Daudigny, Louiza; Cambois, Anne; Moachon, Gilbert; Brown, Peter D.; Campone, Mario
- Publisher
- Springer; Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0344-5704)
- Published
- 2014
- Language
- EN
- Field
- Medicine (Health Sciences)